Fatty Acids Composition and HIV Infection: Altered Levels of n-6 Polyunsaturated Fatty Acids Are Associated with Disease Progression.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
23 07 2023
Historique:
received: 18 05 2023
revised: 11 07 2023
accepted: 18 07 2023
medline: 31 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

Fatty acids (FAs) are important regulators of immune responses and innate defense mechanisms. We hypothesized that disturbed FA metabolism could contribute to the progression of HIV infection. Plasma levels of 45 FAs were analyzed with gas chromatography in healthy controls and HIV-infected patients with regard to Mycobacterium avium complex (MAC) infection. In vitro, we assessed MAC-PPD-induced release of inflammatory cytokines in peripheral and bone marrow mononuclear cells (PBMC and BMMC) according to levels of n-6 polyunsaturated fatty acids (PUFAs). While plasma saturated FAs were higher in HIV infection, PUFAs, and in particular the n-6 PUFA arachidonic acid (AA), were lower in patients with advanced disease. The ratio between AA and precursor dihomo-γ-linolenic acid, reflecting Δ5-desaturase activity, was markedly lower and inversely correlated with plasma HIV RNA levels in these patients. Depletion of AA was observed prior to MAC infection, and MAC-PPD-induced release of TNF and IL-6 in PBMC and BMMC was lower in patients with low plasma AA. Our findings suggest that dysregulated metabolism of n-6 PUFAs may play a role in the progression of HIV infection. While high AA may contribute to chronic inflammation in asymptomatic HIV-infected patients, low AA seems to increase the susceptibility to MAC infection in patients with advanced disease.

Identifiants

pubmed: 37515299
pii: v15071613
doi: 10.3390/v15071613
pmc: PMC10385810
pii:
doi:

Substances chimiques

Fatty Acids, Omega-6 0
Fatty Acids 0
Fatty Acids, Unsaturated 0
Arachidonic Acid 27YG812J1I

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Immunol Rev. 2012 Sep;249(1):72-83
pubmed: 22889216
J Immunol. 2013 Oct 15;191(8):4337-47
pubmed: 24043885
Trends Microbiol. 2013 Jan;21(1):6-13
pubmed: 23062765
AIDS. 2010 Jul 17;24(11):1733-7
pubmed: 20502315
Nature. 2009 Jul 2;460(7251):103-7
pubmed: 19494812
Nat Immunol. 2010 Aug;11(8):751-8
pubmed: 20622882
Am J Clin Nutr. 2010 Mar;91(3):729-35
pubmed: 20071647
J Infect Dis. 2012 Jun;205 Suppl 3:S383-90
pubmed: 22577212
J Am Coll Nutr. 1998 Feb;17(1):25-9
pubmed: 9477386
Metabolism. 2002 Feb;51(2):260-6
pubmed: 11833059
Nature. 2014 Jun 5;510(7503):92-101
pubmed: 24899309
Lancet Infect Dis. 2013 Nov;13(11):964-75
pubmed: 24156897
J Infect Dis. 2007 Oct 15;196(8):1202-10
pubmed: 17955439
Retrovirology. 2017 Sep 29;14(1):45
pubmed: 28962653
Annu Rev Pharmacol Toxicol. 2014;54:407-34
pubmed: 24160702
BMC Infect Dis. 2013 May 04;13:203
pubmed: 23641933
J Intern Med. 2011 Sep;270(3):263-72
pubmed: 21466599
Mar Drugs. 2020 Jun 01;18(6):
pubmed: 32492789
HIV Clin Trials. 2011 Sep-Oct;12(5):268-74
pubmed: 22180524
Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):692-3
pubmed: 20237329
Curr HIV/AIDS Rep. 2019 Jun;16(3):204-213
pubmed: 31037552
J Lipid Res. 2012 Sep;53(9):2002-13
pubmed: 22766885
Microbes Infect. 2008 Oct;10(12-13):1379-86
pubmed: 18771745
Lipids. 1993 Jul;28(7):593-7
pubmed: 8355587
Lipids Health Dis. 2012 Jun 27;11:82
pubmed: 22738017
Cytokine. 2020 Dec;136:155298
pubmed: 32977239
J Immunol Res. 2021 Sep 29;2021:7316456
pubmed: 34631899
J Infect Dis. 2013 Oct 15;208(8):1194-201
pubmed: 23878320
Acta Paediatr. 2005 Jun;94(6):672-7
pubmed: 16188767
Microbes Infect. 2007 Apr;9(4):483-9
pubmed: 17347013
Am J Clin Nutr. 2009 Apr;89(4):1180-7
pubmed: 19244367
J Allergy Clin Immunol. 2014 May;133(5):1255-64
pubmed: 24613565
Immunol Rev. 2012 Sep;249(1):14-26
pubmed: 22889212
PLoS One. 2008 Aug 20;3(8):e3003
pubmed: 18714345
Nutrition. 2000 Jun;16(6):447-53
pubmed: 10869902
Annu Rev Physiol. 2014;76:79-105
pubmed: 24161076
J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):598-605
pubmed: 27529612
Diabetologia. 2015 Nov;58(11):2533-44
pubmed: 26277381
Cell. 2013 Jul 3;154(1):213-27
pubmed: 23827684
J Leukoc Biol. 1997 Dec;62(6):795-804
pubmed: 9400821
Prostaglandins Leukot Essent Fatty Acids. 2006 Sep;75(3):197-202
pubmed: 16828270
Proc Nutr Soc. 2013 Aug;72(3):326-36
pubmed: 23668691

Auteurs

Thor Ueland (T)

Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, NO-0420 Oslo, Norway.
Faculty of Medicine, University of Oslo, NO-0318 Oslo, Norway.
Thrombosis Research Center (TREC), Division of Internal Medicine, University Hospital of North Norway, NO-9038 Tromsø, Norway.

Bjørn Waagsbø (B)

Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, NO-7491 Trondheim, Norway.
Department of Infectious Diseases, St Olav's Hospital, NO-7006 Trondheim, Norway.

Rolf K Berge (RK)

Department of Clinical Science, University of Bergen, NO-5021 Bergen, Norway.
Department of Heart Disease, Haukeland University Hospital, NO-5021 Bergen, Norway.

Marius Trøseid (M)

Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, NO-0420 Oslo, Norway.
Faculty of Medicine, University of Oslo, NO-0318 Oslo, Norway.
Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, NO-0424 Oslo, Norway.

Pål Aukrust (P)

Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, NO-0420 Oslo, Norway.
Faculty of Medicine, University of Oslo, NO-0318 Oslo, Norway.
Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, NO-0424 Oslo, Norway.

Jan K Damås (JK)

Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, NO-7491 Trondheim, Norway.
Department of Infectious Diseases, St Olav's Hospital, NO-7006 Trondheim, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH